Disease Markers

Disease Markers / 2004 / Article

Open Access

Volume 19 |Article ID 826408 | https://doi.org/10.1155/2004/826408

M. P. Gallegos-Arreola, B. C. Gómez-Meda, G. Morgan-Villela, M. R. Arechavaleta-Granell, L. Arnaud-López, T. J. Beltrán-Jaramillo, R. Gaxiola, G. Zúñiga-González, "GSTT1 Gene Deletion Is Associated with Lung Cancer in Mexican Patients", Disease Markers, vol. 19, Article ID 826408, 3 pages, 2004. https://doi.org/10.1155/2004/826408

GSTT1 Gene Deletion Is Associated with Lung Cancer in Mexican Patients

Received13 Jul 2004
Accepted13 Jul 2004


Glutathione S-transferase (GST) is a dimeric detoxifying isoenzyme, involved in the deactivation of carcinogens, several tobacco-derived carcinogens, and xenobiotics. It catalyzes the reduction of glutathione to its thioester; thus, deficiency in GST activity due to homozygous deletion of the GSTT1 gene (null genotype) may play a role in the induction of lung cancer by smoking.We studied the distribution of GSTT1 gene deletion in peripheral blood DNA samples from 178 healthy controls (41 nonsmokers, 63 passive smokers and 74 smokers) and 52 lung cancer patients. Comparisons between groups showed that there was an increased lung cancer risk for individuals with the GSTT1 null genotype. Cancer patients showed significant differences when compared with controls: nonsmokers, passive smokers, and smokers. Twenty-one percent of lung cancer patients carried the deletion versus 2% among nonsmokers not exposed to passive smoking, 6% among passive smokers, and 5% among smokers. Thus, there is a significant association between this genotype and the possibility to risk of developing lung cancer.

Copyright © 2004 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.